A Phase 1, Open-label Study to Evaluate the Safety and Clinical Activity of Azercabtagene Zapreleucel in Participants with B-cell Mediated Autoimmune Disorders

Protocol No
NEURO-TG-AZERCEL-101
Staff Member
Ahmed Obeidat
Phase
I
Summary

This project is being done to learn more about the safety and tolerability of an investigational drug, azercabtagene zapreleucel (azer-cel).
Objective
Azercabtagene Zapreleucel in B-cell Mediated Autoimmune Disorders
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Brain, Spinal Cord, and Nervous System, Other (e.g. headache, autonomics)
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT06680037